| Azacitidine and venetoclax in previously untreated acute myeloid leukemia CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ... New England Journal of Medicine 383 (7), 617-629, 2020 | 2258 | 2020 |
| International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022 | 1808 | 2022 |
| Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia HLM Koskela, S Eldfors, P Ellonen, AJ van Adrichem, H Kuusanmäki, ... New England journal of medicine 366 (20), 1905-1913, 2012 | 898 | 2012 |
| Effects of persistent physical activity and inactivity on coronary risk factors in children and young adults the cardiovascular risk in young Finns study OT Raitakan, KVK Porkka, S Taimela, R Telama, L Räsänen, JS Vllkari American journal of epidemiology 140 (3), 195-205, 1994 | 884 | 1994 |
| BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European … S Soverini, A Hochhaus, FE Nicolini, F Gruber, T Lange, G Saglio, F Pane, ... Blood, The Journal of the American Society of Hematology 118 (5), 1208-1215, 2011 | 757 | 2011 |
| Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score J Hasford, M Baccarani, V Hoffmann, J Guilhot, S Saussele, G Rosti, ... Blood, The Journal of the American Society of Hematology 118 (3), 686-692, 2011 | 681 | 2011 |
| A tumor-homing peptide with a targeting specificity related to lymphatic vessels P Laakkonen, K Porkka, JA Hoffman, E Ruoslahti Nature medicine 8 (7), 751-755, 2002 | 647 | 2002 |
| Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels S Christian, J Pilch, ME Akerman, K Porkka, P Laakkonen, E Ruoslahti The Journal of cell biology 163 (4), 871-878, 2003 | 642 | 2003 |
| Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia K Porkka, P Koskenvesa, T Lundán, J Rimpiläinen, S Mustjoki, R Smykla, ... Blood, The Journal of the American Society of Hematology 112 (4), 1005-1012, 2008 | 545 | 2008 |
| European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia JL Steegmann, M Baccarani, M Breccia, LF Casado, V García-Gutiérrez, ... Leukemia 30 (8), 1648-1671, 2016 | 537 | 2016 |
| Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia T Pemovska, M Kontro, B Yadav, H Edgren, S Eldfors, A Szwajda, ... Cancer discovery 3 (12), 1416-1429, 2013 | 469 | 2013 |
| STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia A Jerez, MJ Clemente, H Makishima, H Koskela, F LeBlanc, K Peng Ng, ... Blood, The Journal of the American Society of Hematology 120 (15), 3048-3057, 2012 | 465 | 2012 |
| A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo K Porkka, P Laakkonen, JA Hoffman, M Bernasconi, E Ruoslahti Proceedings of the National Academy of Sciences 99 (11), 7444-7449, 2002 | 403 | 2002 |
| Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission AH Wei, H Döhner, C Pocock, P Montesinos, B Afanasyev, H Dombret, ... New England Journal of Medicine 383 (26), 2526-2537, 2020 | 391 | 2020 |
| Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy S Mustjoki, M Ekblom, TP Arstila, I Dybedal, PK Epling-Burnette, F Guilhot, ... Leukemia 23 (8), 1398-1405, 2009 | 381 | 2009 |
| Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies B Yadav, T Pemovska, A Szwajda, E Kulesskiy, M Kontro, R Karjalainen, ... Scientific reports 4 (1), 1-10, 2014 | 358 | 2014 |
| Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia HLM Rajala, S Eldfors, H Kuusanmäki, AJ Van Adrichem, T Olson, ... Blood, The Journal of the American Society of Hematology 121 (22), 4541-4550, 2013 | 343 | 2013 |
| Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23 P Pajukanta, I Nuotio, JD Terwilliger, KVK Porkka, K Ylitalo, J Pihlajamäki, ... Nature genetics 18 (4), 369-373, 1998 | 324 | 1998 |
| Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma JA Hoffman, E Giraudo, M Singh, L Zhang, M Inoue, K Porkka, D Hanahan, ... Cancer cell 4 (5), 383-391, 2003 | 314 | 2003 |
| Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3 EM Haapaniemi, M Kaustio, HLM Rajala, AJ van Adrichem, L Kainulainen, ... Blood, The Journal of the American Society of Hematology 125 (4), 639-648, 2015 | 303 | 2015 |
Satu MustjokiUniversity of HelsinkiVerified email at helsinki.fi
